Primmune Therapeutics
UEI: RCE3KW671H83
• CAGE: 8J8L4
Overview
Awardee Type
Parent
Name
Primmune Therapeutics
Website
Headquarters
Carlsbad, CA
United States
United States
Most Recent Award
Jan. 30, 2024
Calculating
Federal contract recipient
PRIMMUNE THERAPEUTICS, INC.
(UEI RCE3KW671H83, CAGE 8J8L4)
is headquartered in Carlsbad CA.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in October 2017 and
federally registered in
March 2020.
Federal Award Analysis
Primmune Therapeutics federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
PRIMMUNE THERAPEUTICS, INC.
UEI
RCE3KW671H83
CAGE Code
8J8L4
SBA Certifications
None
Self Certifications
For Profit Organization
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Oct. 3, 2017
Initial Registration
March 18, 2020
Last Registration
July 25, 2025
Registration Activation
July 22, 2025
Registration Expiration
July 21, 2026
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Accepts Credit Cards
No